The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 23 (9), 1726-1737
- https://doi.org/10.1038/s41436-021-01198-7
Abstract
No abstract availableFunding Information
- KWF Kankerbestrijding (UL2014-7473)
This publication has 37 references indexed in Scilit:
- Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACEJNCI Journal of the National Cancer Institute, 2013
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer RiskPLoS Genetics, 2013
- Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer RiskPLoS Genetics, 2013
- Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriersBritish Journal of Cancer, 2011
- Multiple imputation by chained equations: what is it and how does it work?International Journal of Methods in Psychiatric Research, 2011
- Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk PredictionCancer Research, 2010
- Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older ageBreast Cancer Research and Treatment, 2010
- Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersHuman Molecular Genetics, 2009
- Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersAmerican Journal of Human Genetics, 2008
- An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)Breast Cancer Research, 2007